Search Results - "Jangde, Nitish"
-
1
p32 promotes melanoma progression and metastasis by targeting EMT markers, Akt/PKB pathway, and tumor microenvironment
Published in Cell death & disease (28-10-2021)“…Melanoma originates from melanin-producing cells called melanocytes. Melanoma poses a great risk because of its rapid ability to spread and invade new organs…”
Get full text
Journal Article -
2
MYH9 suppresses melanoma tumorigenesis, metastasis and regulates tumor microenvironment
Published in Medical oncology (Northwood, London, England) (01-10-2020)“…Non-muscle myosin IIA heavy chain (MYH9) has been implicated in many physiological and pathological functions including cell adhesion, polarity, motility to…”
Get full text
Journal Article -
3
Lysophosphatidic acid-RAGE axis promotes lung and mammary oncogenesis via protein kinase B and regulating tumor microenvironment
Published in Cell communication and signaling (27-10-2020)“…Receptor for advanced glycation end products (RAGE) is a multi-ligand transmembrane receptor of the immunoglobulin superfamily. Lysophosphatidic acid (LPA) is…”
Get full text
Journal Article -
4
MDB-37. RAC1 INHIBITION FOR THE TREATMENT OF MEDULLOBLASTOMA
Published in Neuro-oncology (Charlottesville, Va.) (18-06-2024)“…Despite considerable advances in identifying genetic and epigenetic abnormalities in medulloblastoma, many patients succumb to the disease. In addition,…”
Get full text
Journal Article -
5
MDB-41. TARGETING EPIGENETIC REGULATORS TO INHIBIT GROUP 3 MEDULLOBLASTOMA MIGRATION
Published in Neuro-oncology (Charlottesville, Va.) (12-06-2023)“…Abstract Medulloblastoma highly malignant type of childhood brain cancer which develops at the cerebellum. Medulloblastoma can be grouped into four molecular…”
Get full text
Journal Article -
6
EPCO-36. INVESTIGATING THE BAIAP2-CDC42 INTERACTION IN MEDULLOBLASTOMA
Published in Neuro-oncology (Charlottesville, Va.) (14-11-2022)“…Abstract Medulloblastoma is the most common malignant brain tumor found in children. The standard of care is surgical removal, radiation, and chemotherapy…”
Get full text
Journal Article -
7
MODL-14. TARGETING GL1/GL2-DNMT1-UHRF1 EPIGENETIC COMPLEX DISRUPTION VIA BET INHIBITION IMPAIRS SHH MB DEVELOPMENT
Published in Neuro-oncology (Charlottesville, Va.) (18-06-2024)Get full text
Journal Article -
8
ANGI-09. UNRAVELING THE INVOLVEMENT OF BAIAP2 AND CDC42 IN MEDULLOBLASTOMA PATHOGENESIS
Published in Neuro-oncology (Charlottesville, Va.) (10-11-2023)“…Abstract The most common malignant pediatric brain tumor is medulloblastoma. Despite advancements in treatment, medulloblastoma survivors have significant…”
Get full text
Journal Article -
9
Abstract 4307: RAGE is the key receptor for LPA in lung and mammary cancer progression and metastasis
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Lung and breast cancer signaling are very complex; receptor for advanced glycation end products (RAGE) is highly expressed in various cancers and is…”
Get full text
Journal Article -
10
MDB-01. ELUCIDATING THE ROLE OF THE BAIAP2-CDC42 INTERACTION MEDULLOBLASTOMA
Published in Neuro-oncology (Charlottesville, Va.) (12-06-2023)“…Abstract Medulloblastoma is the most common malignant pediatric brain tumor. Despite advancements in treatment, there is still no significant improvement in…”
Get full text
Journal Article -
11
EPCO-37. IDENTIFICATION OF KEY EPIGENETIC REGULATORS FOR MEDULLOBLASTOMA INVASION AND METASTASIS
Published in Neuro-oncology (Charlottesville, Va.) (14-11-2022)“…Abstract Medulloblastoma (MB) is most common type of pediatric brain cancer. It starts from the hind brain or cerebellum. It is actually an embryonic malignant…”
Get full text
Journal Article -
12
MDB-85. THE MIGRATORY ROLE OF BAIAP2 IN MEDULLOBLASTOMA
Published in Neuro-oncology (Charlottesville, Va.) (18-06-2024)Get full text
Journal Article -
13
BSCI-19 A LENTIVIRAL CRISPR SCREEN FOR EPIGENETIC MODULATORS OF ANTIGENS TARGETED BY CAR T CELLS IN GLIOBLASTOMA
Published in Neuro-oncology advances (05-08-2022)“…Abstract Glioblastoma (GBM) is the most common adult brain tumor and is very difficult to treat. One promising treatment strategy is CAR T cell therapy, in…”
Get full text
Journal Article -
14
Cysteine mediated disulfide bond formation in RAGE V domain facilitates its functionally relevant dimerization
Published in Biochimie (01-11-2018)“…Receptor for Advanced Glycation End product (RAGE) is a multiligand receptor implicated in diverse pathological conditions such as diabetes, atherosclerosis,…”
Get full text
Journal Article